IDH2 anticorps (N-Term)

N° du produit ABIN6991363

Détail du produit anti-IDH2 anticorps

Antigène: IDH2 (Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial (IDH2))

Épitope: N-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IDH2 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Purification: IDH2 Antibody is affinity chromatography purified via peptide column.

Immunogène: IDH2 antibody was raised against a 17 amino acid synthetic peptide near the amino terminus of human IDH2. The immunogen is located within the first 50 amino acids of IDH2.

Isotype: IgG

Information d'application

Indications d'application: IDH2 antibody can be used for detection of IDH2 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.

Antibody validated: Western Blot in human samples, Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: IDH2 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: IDH2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur IDH2

Antigène: IDH2 (Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial (IDH2))

Autre désignation: IDH2 (IDH2 Produits)

Synonymes: anticorps F6P23.14, anticorps F6P23_14, anticorps IDH-II, anticorps NAD+ DEPENDENT ISOCITRATE DEHYDROGENASE SUBUNIT 2, anticorps isocitrate dehydrogenase II, anticorps isocitrate dehydrogenase subunit 2, anticorps D2HGA2, anticorps ICD-M, anticorps IDH, anticorps IDHM, anticorps IDP, anticorps IDPM, anticorps mNADP-IDH, anticorps E430004F23, anticorps IDPm, anticorps Idh-2, anticorps wu:fb33c06, anticorps wu:fk31e05, anticorps wu:fq43b01, anticorps zgc:55485, anticorps idh2, anticorps IDH2, anticorps isocitrate dehydrogenase subunit 2, anticorps isocitrate dehydrogenase (NADP(+)) 2, mitochondrial, anticorps isocitrate dehydrogenase 2 (NADP+), mitochondrial, anticorps isocitrate dehydrogenase 2 (NADP+), mitochondrial S homeolog, anticorps isocitrate dehydrogenase [NADP], mitochondrial, anticorps IDH2, anticorps Idh2, anticorps idh2.S, anticorps idh2, anticorps LOC100441867

Sujet: IDH2 Antibody: Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Two NADP(+)-dependent isocitrate dehydrogenases have been found as homodimer: IDH1 is predominantly cytosolic and peroxisomal and IDH2 is mitochondrial. Both IDH1 and IDH2 play significant roles in the tricarboxylic acid cycle (TCA), and defects in IDH1 as well as IDH2 have been implicated in the development of glioma as well as other malignancies.

ID gène: 3418

NCBI Accession: NP_002159

UniProt: P48735

Pathways: L'effet Warburg